RBC Capital reiterates Tesla stock Outperform rating at $500 target By Investing.com

RBC reiterated an Outperform with a $500 price target (stock at $380.97, ~31% upside) while analyst targets span $119–$600 and RBC forecasts Q1'26 deliveries of 367,000 vs Visible Alpha consensus of 369,000. Tesla plans two advanced chip factories (Terafab) in Austin to support its AI/robotaxi push, but Barclays flags higher capex and GLJ downgraded to Sell with a $25.28 target. Regulatory risk intensified as the NHTSA upgraded its FSD probe to an engineering analysis covering ~3.2 million vehicles; model S/X discontinuation and potential FSD recall are additional headwinds. Overall the article presents mixed catalysts—technological upside from chips/robotaxi versus regulatory, product and capex risks—likely to drive idiosyncratic TSLA volatility rather than broad market moves.

Analysis

Tesla's strategic shift toward monetizing fleet-level compute (robotaxi/humanoids emphasis) changes the marginal economics: upside will concentrate in software/attach and utilization rather than unit volume, and that transition typically compresses near-term FCF as capex and R&D front-load while monetization lags 12–36 months. Expect upward pressure on procurement of server-class hardware and mature-node foundry/assembly capacity, which raises input cost volatility for any OEM trying to scale both EV production and AI compute simultaneously.

Regulatory and product-safety scrutiny creates a convex downside to the robotaxi timeline — even modest deployment delays cascade into lower FSD attach rates, deferred revenue recognition, and higher insurance/legal accruals over quarters to years. That regulatory overhang also increases the value of optionality in the supply chain: vendors that can flex capacity quickly or provide turnkey modular compute stacks will capture outsized margin expansion in the next 6–18 months.

Market signal dispersion (wide analyst targets and conflicting capital-intensity narratives) implies elevated event-driven volatility around operational readouts and capex updates. This is a fertile environment for relative-value and event-driven trades: short-duration volatility plays around operational cadence, and multi-month directional pair trades expressing compute beneficiaries vs. capex-challenged OEMs capture the secular divergence between AI infrastructure demand and consumer vehicle demand.

Second-order winners include server OEMs and systems integrators that can convert order backlog into higher ASPs (low-single-digit share gains can translate to double-digit revenue beats for suppliers). Second-order losers are capital-constrained auto OEM peers that must choose between EV volume growth and expensive in-house compute bets — forcing dilution or delayed electrification roadmaps.

Key Decisions for Investors

• Pair trade (6–12 months): Short TSLA equity (size to target 0.7 beta exposure) / Long SMCI (equal dollar) — expresses downside risk to FCF and volume versus upside to AI/server demand. Risk: execution and macro drawdowns; Reward: asymmetric if TSLA faces capex squeeze or regulatory delay while SMCI captures compute spend.
• TSLA options hedge (3 months): Buy 1x1 put spread sized to protect 20–30% of position (buy 3-month put at -10% spot, sell put at -25% spot) — caps cost while preserving upside; target cost <2.5% of notional, payoff kicks in on a material drawdown around near-term operational cadence.
• SMCI directional (9–12 months): Buy SMCI 9–12 month OTM calls (~25–35% OTM) or 100% notional long equity for concentrated exposure to accelerated server demand. Risk: product-cycle timing; Reward: levered participation if AI-related orders accelerate and ASPs rise.
• Event volatility trade on TSLA (30–60 days): Buy a near-dated strangle (delta ~±0.20) into the next operational cadence to monetize expected volatility dispersion between headline beats/misses and longer-term fundamentals. Size to intended gamma exposure; unwind post-catalyst.
• Contrarian short (12 months): Small-sized short TSLA funded by short-term equity or call overwrites — thesis: capex-heavy pivot increases dilution risk if monetization lags and regulatory findings prolong deployment. Reward is high if company is forced to raise capital; risk is sustained multiple expansion if narrative resets positively.